Felicitex Therapeutics Inc. (FLCT)

Felicitex Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2021	2020
Selling, General & Admin	0.78	0.65
Research & Development	0.63	0.49
Operating Expenses	1.41	1.14
Operating Income	-1.41	-1.14
Interest Expense / Income	-0.01	0.04
Other Expense / Income	-0.05	-0.46
Pretax Income	-1.35	-0.72
Net Income	-1.35	-0.72
Free Cash Flow	-0.89	-0.98
EBITDA	-1.35	-0.54
Depreciation & Amortization	0	0.14
EBIT	-1.36	-0.68

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).